Medication info

Vitamin D3 Bion (Cholecalciferol)

Prescription medicationIntramuscular injection
Ingredient · strength
Cholecalciferol›5mg / 1mL
Manufacturer / importer
Kwangdong Pharm Co., Ltd.
Appearance
Colorless transparent ampoule containing odorless, pale yellow transparent injection solution
Packaging
1 ampoule (1 mL/ampoule)
Approval status
Active

MFDS item code 201205962 · Approved 2012.06.28

Summary

Main use
Prevention of vitamin D deficiency in older adults and adolescents; treatment of deficiency in adults, etc.
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, and adjust the dose based on the blood 25-hydroxyvitamin D level. In adults, therapeutic response and tolerability should be reviewed within 3 months after administration of this medicine, and the decision to re-administer should be based on this review. Since overdose may increase adverse reactions, do not administer more than the required amount. - Adults: Administer 200,000IU of cholecalciferol by intramuscular injection. - Elderly patients: Administer 100,000IU of cholecalciferol by intramuscular injection. Do not exceed an annual dose of 600,000IU of cholecalciferol.
Child administration
In adolescents, therapeutic response and tolerability should be reviewed within 6 months after administration of this medicine, and the decision to re-administer should be based on this review. - Adolescents: Administer 200,000IU of cholecalciferol by intramuscular injection.

Ingredients

Importer
Kwangdong Pharm Co., Ltd.

Efficacy & effects

Prevention of vitamin D deficiency in older adults and adolescents; treatment of deficiency in adults, etc.

  • Vitamin D deficiency
View approved original text

This medication is used to prevent and treat vitamin D deficiency in elderly individuals, adolescents, and adults who have a shortage of vitamin D. Vitamin D plays an important role in maintaining bone health and immune function, thereby improving deficiency states and promoting health.

How it is given

Adult administration

Use as prescribed by a physician, and adjust the dose based on the blood 25-hydroxyvitamin D level. In adults, therapeutic response and tolerability should be reviewed within 3 months after administration of this medicine, and the decision to re-administer should be based on this review. Since overdose may increase adverse reactions, do not administer more than the required amount. - Adults: Administer 200,000IU of cholecalciferol by intramuscular injection. - Elderly patients: Administer 100,000IU of cholecalciferol by intramuscular injection. Do not exceed an annual dose of 600,000IU of cholecalciferol.

Child administration

In adolescents, therapeutic response and tolerability should be reviewed within 6 months after administration of this medicine, and the decision to re-administer should be based on this review. - Adolescents: Administer 200,000IU of cholecalciferol by intramuscular injection.

Precautions

Since this medication contains vitamin D, the total intake must be checked when taken with vitamin D fortified foods or other vitamin D preparations. Regular monitoring of calcium levels in blood and urine must be conducted, and the administration should be discontinued immediately if exceeding the normal range. It is especially important to frequently monitor calcium levels in the blood and urine if calcium intake is high. This medication should not be used in patients with certain diseases or impaired renal function, as well as in pregnant or breastfeeding women. Various side effects such as headaches, fatigue, muscle pain, digestive disorders, dehydration, hypertension, and kidney issues may occur, so any abnormal symptoms should be immediately discussed with healthcare professionals. Injection sites may develop inflammation or rashes, so it is essential to keep the injection site clean and monitor closely. When administered to patients with vitamin D deficiency, serum vitamin D levels should be regularly checked to prevent overdosing. In particular, elderly patients or those taking specific medications should undergo regular renal function tests and dosage adjustments if necessary. There may be interactions with certain medications, thus it is crucial to inform healthcare providers about any other medications being taken. During pregnancy, the use of this medication should be avoided as there is a risk of fetal abnormalities due to hypercalcemia. The safety and efficacy in children under 12 years of age have not been established; hence, usage is not recommended. In case of overdose, administration should be immediately discontinued, calcium intake reduced, and hydration maintained to regulate body calcium levels through diuresis. This medication should not be mixed with other drugs and should be used quickly after opening; any remaining medication should be discarded. For storage, it is safe to keep it in a sealed container to avoid exposure to air or light, away from direct sunlight at a temperature range of 1 to 25 degrees Celsius. This helps maintain the efficacy and prevent degradation of the medication.

Side effects

Headache, weakness, fatigue, muscle pain, loss of appetite, weight loss, growth retardation, nausea, vomiting, constipation, diarrhea, polyuria, polydipsia, dehydration, hypertension, calcium stones, tissue calcification of kidneys and blood vessels, renal impairment, excessive bone calcification, arrhythmia, psychological symptoms, consciousness disturbance, arthralgia, myasthenia, drowsiness, azotemia, hypersensitivity reaction, thirst, confusion, bloating, abdominal pain, metallic taste, dry mouth, rash, itching, hypercalciuria, hypercalcemia, hyperphosphatemia, hyperphosphaturia, injection site granuloma, injection site nodule, injection site reaction, injection site urticaria, injection site infection

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a sealed container to prevent exposure to air or light, kept in a cool place away from direct sunlight at a temperature range of 1 to 25 degrees Celsius. By doing so, the efficacy is maintained and degradation is prevented.

Appearance and packaging

Appearance

Colorless transparent ampoule containing odorless, pale yellow transparent injection solution

Package unit

1 ampoule (1 mL/ampoule)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.